Association of fecal calprotectin and lipocalin-2 with subclinical intestinal inflammation and disease activity in patients with axial spondyloarthritis
Background Axial spondyloarthropathy (axSpA) are group of diseases with inflammatory low back pain, asymmetrical oligoarthritis, HLA-B27 positivity and extra-articular manifestations. Asymptomatic subclinical gut inflammation and impaired integrity of intestinal mucosa macroscopically and microscopi...
Saved in:
| Main Authors: | Eman Abdel Ghani Sayed, Anna Abou-Raya, Mona Wagdy Ayad, Omnia Mohamed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Alexandria Journal of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20905068.2024.2418134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Colitis in spondyloarthritis
by: Muhammed Hafis, et al.
Published: (2020-01-01) -
Reducing Diagnostic Delay in Axial Spondyloarthritis: Could Lipocalin 2 Biomarkers Help?
by: Kenneth P. H. Pritzker, et al.
Published: (2024-11-01) -
The Role of Fecal Calprotectin in Investigating Pediatric Ulcerative Colitis
by: Fatih Ünal, et al.
Published: (2012-12-01) -
Effect of past extensive ulcers on fecal calprotectin in ulcerative colitis
by: Natsuki Ishida, et al.
Published: (2024-11-01) -
Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?
by: Büşra Tetik Dinçer, et al.
Published: (2024-12-01)